Disease | hepatitis b |
Symptom | |hepatocellular carcinoma |
Sentences | 143 |
PubMedID- 22212935 | Prevention of hepatocellular carcinoma in patients with chronic hepatitis b virus infection. |
PubMedID- 25983748 | The role of tlr3 in hepatocellular carcinoma (hcc) with hepatitis b virus (hbv) infections is not well understood. |
PubMedID- 24583062 | Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis b treated with entecavir vs lamivudine. |
PubMedID- 23781497 | Evaluated the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection and found that the c > t polymorphisms at foki position in the vdr gene served as a potential biomarker for the risk and the disease severity of hcc in those infected with hbv. |
PubMedID- 26159441 | Background: this study was designed to evaluate the prognostic value of three systemic inflammation markers, neutrophil to lymphocyte ratio (nlr), platelet to lymphocyte ratio (plr), and prognostic nutritional index (pni), for hepatocellular carcinoma (hcc) associated with hepatitis b (hbv). |
PubMedID- 22675319 | The expression of dlk1-dio3 mirna was examined in 97 patients with hepatocellular carcinoma (hcc) associated with hepatitis b infection. |
PubMedID- 21809355 | We aimed to investigate the incidence of occult hepatitis b infection (obi) in patients with "cryptogenic" hepatocellular carcinoma (hcc) and to study the hbv replicative activity in these patients. |
PubMedID- 20924214 | Background/aims: whether alcohol intake increases the risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection remains controversial. |
PubMedID- 25873850 | The present case was a young man, a known case of chronic hepatitis b with multiple recurrent hepatocellular carcinoma, who presented with clinical sepsis and jaundice. |
PubMedID- 24614696 | Background: risk factors can affect candidacy and prognosis following orthotopic liver transplantation (olt) with antiviral prophylaxis for the treatment of hepatocellular carcinoma (hcc) associated with hepatitis b virus (hbv) and cirrhosis. |
PubMedID- 25735064 | A 65-year-old woman had previously undergone ldlt for hepatocellular carcinoma associated with hepatitis b virus infection. |
PubMedID- 23615731 | A tissue microarray containing hepatocellular carcinoma samples with hepatitis b-positive patients (50 cases, 2 cores per case) and two non-neoplastic liver samples (2 cores per sample) was purchased from accumax (a217). |
PubMedID- 23250907 | Enhancers and attenuators of risk associations of chronic hepatitis b virus infection with hepatocellular carcinoma in type 2 diabetes. |
PubMedID- 24570914 | Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis b virus infection. |
PubMedID- 25312649 | The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis b on long-term nucleos(t)ide analogue therapy. |
PubMedID- 23586065 | Aim: to evaluate the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection. |
PubMedID- 22271485 | Statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection. |
PubMedID- 24570913 | Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis b. |
PubMedID- 26350363 | Background: hepatocellular carcinoma (hcc) not associated with active hepatitis b virus (hbv) or hepatitis c virus (hcv) infection, termed non-b non-c hcc (nbnc-hcc), is reportedly correlated with better survival outcomes than hbv- or hcv-related hcc. |
PubMedID- 25478255 | A 62-year-old woman, with cirrhosis due to hepatitis b associated with hepatocellular carcinoma, was submitted to living donor liver transplantation. |
PubMedID- 24148650 | Outcomes following liver resection and clinical pathologic characteristics of hepatocellular carcinoma occurring in patients with chronic hepatitis b and minimally fibrotic liver. |
PubMedID- 24745029 | We evaluated clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-b non-c (nbnc) hepatocellular carcinoma (hcc) patients with comparison to hepatitis b or c virus, paying attention to relationship between alcohol consumption and histopathological findings. |
PubMedID- 22444598 | Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis b infection. |
PubMedID- 26421022 | The objective of this study was to investigate risk factors for intrahepatic recurrence after resection of hepatocellular carcinoma, especially in patients with hepatitis b virus infection. |
PubMedID- 24023999 | A 49 year-old woman (160.0 cm, 94.6 kg) suffering from hepatocellular carcinoma with end-stage hepatitis b liver cirrhosis (model for end stage liver disease meld score 14, child-pugh class b) presented for living donor lt. she had hypertension that was well controlled with medications. |
PubMedID- 21319289 | Second neoplasms appeared in 3 patients, 1 of whom died of hepatocellular carcinoma following infection with hepatitis b. |
PubMedID- 24995497 | Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis b virus infection. |
PubMedID- 24930484 | Here, we assessed the prognostic performance of lsps in predicting the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb). |
PubMedID- 24704525 | Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis b: a nationwide cohort study. |
PubMedID- 22819910 | Background/aims: we investigated the clinicopathological findings and outcome after surgery for hepatocellular carcinoma in patients without hepatitis b or c virus infection. |
PubMedID- 23044807 | Association of xrcc1, xrcc3, and xpd genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis b and c virus. |
PubMedID- 22972059 | Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis b. |
PubMedID- 22231575 | Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis b virus infection. |
PubMedID- 22436980 | Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis b virus infection--results from a clinic-based longitudinal cohort. |
PubMedID- 24976705 | hepatitis b virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy. |
PubMedID- 21104161 | Association of novel mutations and haplotypes in the pres region of hepatitis b virus with hepatocellular carcinoma. |
PubMedID- 24312130 | To investigate whether killer cell immunoglobulin-like receptor (kir) and human leukocyte antigen (hla) genetic background could influence the onset age of hepatocellular carcinoma (hcc) in patients with hepatitis b virus (hbv) infection, one hundred and seventy-one males with hbv-related hcc were enrolled. |
PubMedID- 23898389 | Patients less than 18 years old; patients with neoplasm including hemangioma, liver cyst, and hepatocellular carcinoma; coinfection of hepatitis b and c; hepatitis b healthy carrier with normal transaminase; alcoholic liver disease (20 g/day or more for males, 10 g/day or more for females); autoimmune hepatitis; and metabolic liver diseases such as wilson's disease were other criteria of exclusion. |
PubMedID- 23098862 | Chronic infection with the hepatitis b virus can lead to hepatocellular carcinoma and cirrhosis in up to 25% of infected individuals. |
PubMedID- 24387289 | Background: chronic hepatitis b (chb) may lead to cirrhosis, hepatocellular carcinoma and premature death. |
PubMedID- 24576055 | Background & aims: the aim of this study was to re-evaluate the diagnostic performance of alpha-foetoprotein (afp) as a surveillance test for hepatocellular carcinoma (hcc) in patients with hepatitis b virus-related chronic liver disease who were treated with entecavir (etv). |
PubMedID- 24485003 | Thus, the present study was designed to investigate the protective effect of s-adenosylmethionine (same) on hiri, especially for patients with hepatocellular carcinoma (hcc) associated with chronic hepatitis b virus (hbv) infection and cirrhosis. |
PubMedID- 22118340 | The chb natural history influenced density of tumour-infiltrating tregs in hepatocellular carcinoma patients with chronic hepatitis b viruses infection. |
PubMedID- 23236406 | The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis b virus infection and cirrhosis. |
PubMedID- 26133818 | Correlation between polymorphisms in the human leukocyte antigen-dqb1 alleles and hepatitis b with primary hepatocellular carcinoma. |
PubMedID- 24393929 | A 61-year-old man who complained of right hypochondralgia was diagnosed as hepatocellular carcinoma (hcc) associated with hepatitis b virus (hbv) infection. |
PubMedID- 24122900 | Does long-term entecavir treatment really reduce hepatocellular carcinoma incidence in patients with hepatitis b virus infection. |
PubMedID- 22372460 | hepatocellular carcinoma (hcc) in a patient with hepatitis b virus (hbv) infection. |
PubMedID- 21480326 | Few studies have evaluated the risk of cancers other than hepatocellular carcinoma associated with hepatitis b virus (hbv) infection. |
PubMedID- 23661457 | Evaluation of a histocompatibility antigen related to hepatitis b virus in patients with hepatocellular carcinoma in the western brazilian amazon. |